Differential effects of isoflurane and sevoflurane on action potential duration in subendocardial and subepicardial myocytes isolated from the rat left ventricle

University of Bristol (2001) J Physiol 536P, S136

Communications: Differential effects of isoflurane and sevoflurane on action potential duration in subendocardial and subepicardial myocytes isolated from the rat left ventricle

Amber Rithalia, Mark R. Boyett, Philip M. Hopkins* and Simon M. Harrison

School of Biomedical Sciences and *Academic Unit of Anaesthesia, University of Leeds, Leeds LS2 9JT, UK

View other abstracts by:


In healthy ventricular tissue, expression of the transient outward K+ current is greater in subepicardial (EPI) than subendocardial (ENDO) cells (Antzelevitch et al. 1991) contributing to the shorter action potential in the sub-epicardium. This transmural gradient of action potential duration (APD) is important for normal repolarisation of the ventricle. We have demonstrated previously that 0.6 mM halothane (~2 Ω MAC50) decreased APD to a greater extent in ENDO than EPI cells (Rithalia et al. 2001), reducing the normal transmural dispersion of repolarisation which may contribute to the arrhythmogenic properties of halothane. Here we examine the effects of isoflurane and sevoflurane, volatile anaesthetics with less pronounced arrhythmogenic properties, on APD in ENDO and EPI cells.

Hearts were removed from male Wistar rats (weight, 200-250 g; Schedule 1 method) and cells isolated from the subendocardium and subepicardium of the left ventricle with a standard enzymatic dissociation protocol. Action potential recordings were made at 30 °C using the perforated-patch technique in current-clamp mode before, during and after a 1 min exposure to 0.6 mM isoflurane or sevoflurane (~2 Ω MAC50 for both). APD was measured as time (ms) from the peak of the action potential to repolarisation at 0 mV (APD0 mV) and -50 mV (APD-50 mV). Data are expressed as means ± S.E.M. Significance was determined with paired or unpaired t tests.

In both control groups, APD was longer in ENDO than EPI cells at both 0 and -50 mV (P < 0.01 for both). Isoflurane decreased APD in ENDO cells; e.g. APD-50 mV was reduced from 44 ± 7 to 33 ± 5 ms; P < 0.05, n = 7 (Fig. 1), but had no effect on APD in EPI cells. Sevoflurane significantly reduced APD-50 mV from 39 ± 6 to 33 ± 5 ms (P < 0.05, n = 7) but not APD0 mV in ENDO cells. In EPI cells, sevoflurane reduced APD-50 mV from 16 ± 2 to 15 ± 1 ms (P < 0.05, n = 8) but with no change in APD0 mV.Comparing the above data with halothane, all three anaesthetics (at 0.6 mM, ~2 Ω MAC50) reduced APD to a greater extent in ENDO than EPI cells such that the mean transmural APD-50 mV was decreased to 49, 64 and 78 % of control for halothane, isoflurane and sevoflurane, respectively. The differential effects on transmural APD of the three anaesthetics may help elucidate their differential transmural negative inotropic effects and arrhythmogenic properties.This work was supported by The British Heart Foundation.

figure one
Figure 1. Action potential duration (mean ± S.E.M.) of ENDO and EPI cells under control conditions and following a 1 min exposure to 0.6 mM isoflurane (ISO) or sevoflurane (SEVO). *P < 0.05, **P < 0.01, ***P < 0.001.
    Antzelevitch, C., Sicouri, S., Litovsky, S.H., Lukas, A., Krishnan, S.C., Di Diego, J.M., Gintant, G.A. & Liu, D.-W. (1991). Circ. Res. 69, 1427-1449.

    Rithalia, A., Boyett, M.R., Hopkins, P.M. & Harrison, S.M. (2001). Br. J. Anaesth. 86 (2), 317P.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type